Toolkit Items

Browse the toolkit beneath workflows. The mechanism branch runs mechanism -> architecture -> component, while the technique branch runs from high-level approaches down to concrete methods.

6 items matching 1 filter

Mechanism Branch

Layer 1

Mechanisms

▾

Top-level concepts: biophysical action modes such as heterodimerization, photocleavage, or RNA binding.

Layer 2

Architectures

▾

Arrangements that realize or deploy mechanisms, including switches, construct patterns, and delivery strategies.

Layer 3

Components

▾

Low-level parts and sequence-defined elements used inside architectures, including protein domains and RNA elements.

Technique Branch

Layer 1

Approaches

▾

High-level engineering practices such as computational design, directed evolution, sequence verification, and functional assay.

Layer 2

Methods

▾

Concrete methods used to design, build, verify, or characterize engineered systems.

Sort

controlled release

Showing 1-6 of 6

Loaditems

Page 1 / 1

lipid-polymer hybrid nanoparticles

Delivery Strategy

Since 2025cd44-mediated targeted delivery controlled release endosomal escape redox-responsive release sustained releaseTranslation ControlComputational DesignStructural Characterization

Lipid-polymer hybrid nanoparticles (LPHNPs) are the next-generation nanocarriers that integrate the mechanical strength and sustained-release capacity of polymeric cores with the biocompatibility and high drug-loading efficiency of lipid shells.

CFBacMamMusHumTxRep

Ev 37Rep 20Pr 83

lipid nanoparticle-based mRNA therapeutics

Delivery Strategy

Since 2026controlled release intracellular delivery targeted release translation controlTranslation Control

The COVID-19 pandemic marked a turning point in vaccine development, leading to the swift creation of mRNA vaccines delivered via lipid nanoparticles (LNP-mRNA).

CFBacMamMusHumTxRep

Ev 28Rep 9Pr 71

spatial-temporal control of bioactive drug release

Engineering Method

Since 2019controlled release spatiotemporal patterning of bioactive factor delivery

Spatial-temporal control of bioactive drug release is an engineering method for delivering developmental cytokines, growth factors, and other bioactive factors in defined spatial and temporal patterns. In the cited 2019 review, it is described as a well-developed approach that makes biomimetic release strategies more feasible for tooth regeneration.

CFBacMamMusHumTxRep

Ev 20Rep 9Pr 71

encapsulated probiotics

Delivery Strategy

controlled release physical encapsulation protective shielding of probiotic payloads site-specific release

Encapsulation technologies ... have substantially improved probiotic viability, storage stability, and site-specific release. ... Collectively, encapsulated probiotics represent a potent strategy for combating AMR by enhancing antimicrobial efficacy and therapeutic consistency.

CFBacMamMusHumTxRep

liposomes

Delivery Strategy

controlled release encapsulation light-triggered release targeted deliveryComputational Design

A multitude of substances are currently under investigation for the preparation of nanoparticles for drug delivery, varying from biological substances like albumin, gelatine and phospholipids for liposomes

CFBacMamMusHumTxRep

metal-organic framework nanocarriers

Delivery Strategy

controlled release

Emerging carriers such as dendrimers, self-assembling peptides, mesoporous silica, and metal-organic frameworks (MOFs) further enhance controlled release and specificity.

CFBacMamMusHumTxRep

Page 1 / 1